在ICU患者感染性血小板缺血的ADAMTS-13行为
V Dinesh K Gontla1, Srinivas Samavedam2, Narmada Aluru3
1Department of Critical Care Medicine, Aster Ramesh Hospitals, Vijayawada, Andhra Pradesh, India.
概括
减少ADAMTS-13活性与患有病毒和非病毒感染的ICU患者的严重血小板缺血有关. 较低的水平,特别是在非病毒病例中,表明疾病严重程度较高,但不一定需要增加输血需求.
科学领域:
- 血液学 血液学 血液学
- 关键护理医学 关键护理医学
- 传染性疾病 传染性疾病
背景情况:
- 血小板缺血是重症监护室 (ICU) 患者常见的并发症.
- 一种类似分解蛋白的金属蛋白酶和类似血栓蛋白的活性动机13 (ADAMTS-13) 对于调节威尔布兰德因子 (vWF) 活性和防止血小板过度聚集至关重要.
- 了解ADAMTS-13在感染相关的血小板缺血中的作用对于患者管理至关重要.
研究的目的:
- 调查ADAMTS-13水平与ICU患者病毒性和非病毒性感染中血小板缺血的严重程度之间的关联.
- 探索ADAMTS-13活动,感染类型和临床结果 (如出血和输血要求) 之间的相关性.
- 评估ADAMTS-13在感染诱导的血小板缺血中的预后价值.
主要方法:
- 一项前性观察性研究,涉及成年ICU患者,被诊断患有血栓细胞减小.
- 患者被分为病毒性和非病毒性感染组.
- 进行了统计分析,以将ADAMTS-13水平与血小板缺血的严重程度,出血发作,输血需求和整体结果相关联.
主要成果:
- 较低的ADAMTS-13活性与病毒和非病毒感染组的血小板缺血严重程度增加显著相关 (p <0.05).
- 在患有非病毒性感染的患者中观察到ADAMTS-13活性更明显的缺陷.
- 尽管ADAMTS-13水平与出血发作和血小板缺血的进展相关,但尽管血小板数量低,但并没有预测输血需求的增加.
结论:
- 减少ADAMTS-13活性与ICU患者的血小板缺血的严重程度有关,特别是在非病毒性感染中.
- 由于ADAMTS-13的耗尽和vWF活性升高,可能会导致感染相关的血小板狭窄症的发病.
- 亚当斯-13水平可以作为一个有价值的生物标志物,用于评估血栓细胞减小的严重程度和预后,指导早期管理和输血策略.
相关概念视频
02:45Blood Transfusion and Agglutination
Blood transfusion is a therapeutic measure to restore the blood volume after extensive blood loss due to an accident or a medical procedure. Blood transfusion involves drawing a certain amount of blood from a suitable donor and infusing it into the recipient.
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
01:18Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
01:24Disorders of Hemostasis
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
01:18Endocarditis III: Medical Management
Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
01:29Venous Thrombosis III: Interprofessional Care
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
01:30Venous Thrombosis IV: Nursing Management
Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...